A Global Breast Reconstruction Market Size study & Forecast, by Product ( Implants, Tissue Expander

Global Breast Reconstruction Market Size study & Forecast, by Product ( Implants, Tissue Expander, Acellular Dermal Matrix) by Shape ( Round Shape, Anatomical Shape), by End Use (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers) and Regional Analysis, 2022-2029

Global Breast Reconstruction Market is valued approximately USD 465.3 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2022-2029. Breast reconstruction is most frequently performed on women who have undergone surgery to treat breast cancer, involves reconstructing the shape and appearance of a breast surgically. It aims to reconstruct a natural-looking breast using autologous tissue, artificial implants, or a combination of both. The Breast Reconstruction market is expanding because of factors such as global increase in number of breast cancer women patients and increasing awareness & acceptability of breast reconstruction among women with breast cancer. However, increasing alternative to breast reconstruction and complication due to a breast implant may halt market growth.

According to World Health Organization, in year 2020, there were around 2.3 million women who had diagnose with breast cancer. Over the past five years, breast cancer has been detected in almost 7.8 million women. With 22.9% of all female cancer cases in 2020 occurring in Asian women, breast cancer is highly prevalent in this population. Women undergoing mastectomy and other breast cancer procedures are being encouraged to choose the reconstruction process. Thus high prevelance of breast cancer across the globe is augmenting the market growth. Moreover, The market is expected to rise as a result of an increase in breast reconstruction surgeries. For instance, according to the NCBI, the proportion of women who get breast reconstruction following mastectomy rose from 19.4% in 2015 to 53.4% in 2018. The American Society of Plastic Surgeons further claims that the number of breast reconstruction operations climbed from 78,882 in 2000 to 137,808 in 2020, driving the market's expansion. In addition, increasing number of breast reconstructive procedures and technological advancements in product development activities is catering the market growth. However, the high cost of Breast Reconstruction stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Breast Reconstruction Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing prevelance of breast cancer. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for biosimilar product development, geographic expansion of key players.

Major market player included in this report are:
Mentor Medical Systems B.V. (Johnson & Johnson)
Abbvie (Allergan Inc.)
Integra Lfesciencs Corporation
Sientra, Inc.
Stryker Corporation
Establishment Labs Holding, Inc. (Motiva Usa Llc)
RTI Surgical
MTF Biologics
Sia (Surgical Innovation Associates)
Tela Bio, Inc

Recent Developments in the Market:
 In 2022, GC Aesthetics unveiled FixNip NRI, a new implant for repairing the areola complex (NAC). This medical device satisfies a recognised clinical need for thousands of women worldwide.
 In 2021, The US FDA has authorised a new MENTOR Memory Gel enhance breast implant from Mentor Worldwide LLC (Johnson & Johnson).

Global Breast Reconstruction Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Shape, End Use Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Implants
Tissue Expander
Acellular Dermal Matrix

By Shape:
Round Shape
Anatomical Shape

By End Use:
Hospitals
Cosmetology Clinics
Ambulatory Surgical Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Mentor Medical Systems B.V. (Johnson & Johnson)
Abbvie (Allergan Inc.)
Integra Lfesciencs Corporation
Sientra, Inc.
Stryker Corporation
Establishment Labs Holding, Inc. (Motiva Usa Llc)
RTI Surgical
MTF Biologics
Sia (Surgical Innovation Associates)
Tela Bio, Inc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.